Stephen R.D. Johnston

2.7k total citations
45 papers, 1.9k citations indexed

About

Stephen R.D. Johnston is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Stephen R.D. Johnston has authored 45 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 21 papers in Genetics and 17 papers in Molecular Biology. Recurrent topics in Stephen R.D. Johnston's work include Estrogen and related hormone effects (21 papers), HER2/EGFR in Cancer Research (19 papers) and Breast Cancer Treatment Studies (16 papers). Stephen R.D. Johnston is often cited by papers focused on Estrogen and related hormone effects (21 papers), HER2/EGFR in Cancer Research (19 papers) and Breast Cancer Treatment Studies (16 papers). Stephen R.D. Johnston collaborates with scholars based in United Kingdom, United States and Denmark. Stephen R.D. Johnston's co-authors include Mitch Dowsett, Anthony Howell, Sacha J. Howell, Roger A’Hern, L Pyle, Matthew Vaughan, Tim Eisen, Martin Gore, Ian Mak and Chris Boshoff and has published in prestigious journals such as Journal of Clinical Oncology, Nature reviews. Cancer and The Lancet Oncology.

In The Last Decade

Stephen R.D. Johnston

42 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen R.D. Johnston United Kingdom 22 935 844 726 472 288 45 1.9k
R.I. Nicholson United Kingdom 25 1.1k 1.1× 884 1.0× 1.0k 1.4× 582 1.2× 283 1.0× 63 2.3k
Janice M. Knowlden United Kingdom 23 1.2k 1.3× 1.1k 1.3× 810 1.1× 428 0.9× 318 1.1× 37 2.1k
Carolyn Sidor United States 20 553 0.6× 871 1.0× 280 0.4× 433 0.9× 147 0.5× 42 1.6k
Björn Erikstein Norway 24 1.3k 1.4× 859 1.0× 968 1.3× 702 1.5× 483 1.7× 47 2.7k
I. E. Smith United Kingdom 16 900 1.0× 485 0.6× 597 0.8× 422 0.9× 340 1.2× 37 1.7k
T. Tominaga Japan 18 825 0.9× 730 0.9× 459 0.6× 720 1.5× 236 0.8× 82 1.7k
Roger Keresztes United States 19 1.1k 1.2× 655 0.8× 295 0.4× 456 1.0× 631 2.2× 37 2.7k
Paola Papaldo Italy 25 1.1k 1.2× 411 0.5× 235 0.3× 439 0.9× 336 1.2× 66 1.7k
Charles Morris United Kingdom 12 1.8k 1.9× 695 0.8× 1.1k 1.5× 527 1.1× 1.2k 4.1× 21 2.7k
Jean‐Marc Nabholtz France 24 1.9k 2.0× 508 0.6× 1.2k 1.6× 1.3k 2.8× 772 2.7× 54 3.2k

Countries citing papers authored by Stephen R.D. Johnston

Since Specialization
Citations

This map shows the geographic impact of Stephen R.D. Johnston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen R.D. Johnston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen R.D. Johnston more than expected).

Fields of papers citing papers by Stephen R.D. Johnston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen R.D. Johnston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen R.D. Johnston. The network helps show where Stephen R.D. Johnston may publish in the future.

Co-authorship network of co-authors of Stephen R.D. Johnston

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen R.D. Johnston. A scholar is included among the top collaborators of Stephen R.D. Johnston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen R.D. Johnston. Stephen R.D. Johnston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Angelis, Vasileios, Stephen R.D. Johnston, Amin Ardestani, & Kathrin Maedler. (2022). Case Report: Neratinib Therapy Improves Glycemic Control in a Patient With Type 2 Diabetes and Breast Cancer. Frontiers in Endocrinology. 13. 830097–830097. 7 indexed citations
2.
Bhaludin, Basrull, Nina Tunariu, Dow‐Mu Koh, et al.. (2022). A review on the added value of whole-body MRI in metastatic lobular breast cancer. European Radiology. 32(9). 6514–6525. 9 indexed citations
3.
A’Hern, Roger, Mariam Jamal‐Hanjani, Attila Marcell Szász, et al.. (2013). Taxane benefit in breast cancer—a role for grade and chromosomal stability. Nature Reviews Clinical Oncology. 10(6). 357–364. 32 indexed citations
4.
Sharma, Bhupinder, et al.. (2012). Imaging in oncology—over a century of advances. Nature Reviews Clinical Oncology. 9(12). 728–737. 20 indexed citations
5.
Burrell, Rebecca A., N. Juul, Stephen R.D. Johnston, et al.. (2010). Targeting chromosomal instability and tumour heterogeneity in HER2‐positive breast cancer. Journal of Cellular Biochemistry. 111(4). 782–790. 39 indexed citations
6.
McIllmurray, M B, et al.. (2008). Vinorelbine and Infusional 5-fluorouracil in Anthracycline and Taxane Pre-treated Metastatic Breast Cancer. Clinical Oncology. 20(2). 152–156. 8 indexed citations
7.
Johnston, Stephen R.D., Lesley‐Ann Martin, Alexandra Léary, Julia E. Head, & Mitch Dowsett. (2007). Clinical strategies for rationale combinations of aromatase inhibitors with novel therapies for breast cancer. The Journal of Steroid Biochemistry and Molecular Biology. 106(1-5). 180–186. 41 indexed citations
8.
Léary, Alexandra & Stephen R.D. Johnston. (2007). Small Molecule Signal Transduction Inhibitors for the Treatment of Solid Tumors. Cancer Investigation. 25(5). 347–365. 14 indexed citations
9.
Delea, Thomas E., Jonathan Karnon, Robert E. Smith, et al.. (2006). Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.. PubMed. 12(7). 374–86. 37 indexed citations
10.
Karnon, Jonathan, Thomas E. Delea, Stephen R.D. Johnston, et al.. (2006). Cost Effectiveness of Extended Adjuvant Letrozole in Postmenopausal Women after Adjuvant Tamoxifen Therapy. PharmacoEconomics. 24(3). 237–250. 31 indexed citations
11.
Johnston, Stephen R.D., Lesley‐Ann Martin, Julia E. Head, Ian Smith, & Mitch Dowsett. (2005). Aromatase inhibitors: Combinations with fulvestrant or signal transduction inhibitors as a strategy to overcome endocrine resistance. The Journal of Steroid Biochemistry and Molecular Biology. 95(1-5). 173–181. 52 indexed citations
12.
Urruticoechea, Ander, Caroline Archer, L. Assersohn, et al.. (2005). Mitomycin C, vinblastine and cisplatin (MVP): an active and well-tolerated salvage regimen for advanced breast cancer. British Journal of Cancer. 92(3). 475–479. 14 indexed citations
13.
Howell, Sacha J., Stephen R.D. Johnston, & Anthony Howell. (2003). The use of selective estrogen receptor modulators and selective estrogen receptor down-regulators in breast cancer. Best Practice & Research Clinical Endocrinology & Metabolism. 18(1). 47–66. 109 indexed citations
14.
Johnston, Stephen R.D. & Mitch Dowsett. (2003). Aromatase inhibitors for breast cancer: lessons from the laboratory. Nature reviews. Cancer. 3(11). 821–831. 238 indexed citations
15.
Boer, Richard H. De, Tim Eisen, Peter Ellis, et al.. (2002). A randomised phase II study of conventional versus accelerated infusional chemotherapy with granulocyte colony-stimulating factor support in advanced breast cancer. Annals of Oncology. 13(6). 889–894. 5 indexed citations
16.
Johnston, Stephen R.D.. (2001). Farnesyl transferase inhibitors: a novel targeted therapy for cancer. The Lancet Oncology. 2(1). 18–26. 105 indexed citations
17.
Saunders, Y, Justin Stebbing, Karen Broadley, & Stephen R.D. Johnston. (2001). Recurrent Locally Advanced Breast Cancer: The Treatment of Chest Wall Disease with Further Chemotherapy. Clinical Oncology. 13(3). 195–199. 6 indexed citations
18.
Johnston, Stephen R.D.. (2001). Systemic treatment of metastatic breast cancer. Hospital Medicine. 62(5). 289–295. 7 indexed citations
19.
Johnston, Stephen R.D.. (1997). Acquired tamoxifen resistance in human breast cancer–potential mechanisms and clinical implications. Anti-Cancer Drugs. 8(10). 911–930. 111 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R.I. Nicholson Breakdown of academic impact, for papers by Janice M. Knowlden Breakdown of academic impact, for papers by Carolyn Sidor Breakdown of academic impact, for papers by Björn Erikstein Breakdown of academic impact, for papers by I. E. Smith Breakdown of academic impact, for papers by T. Tominaga Breakdown of academic impact, for papers by Roger Keresztes Breakdown of academic impact, for papers by Paola Papaldo Breakdown of academic impact, for papers by Charles Morris Breakdown of academic impact, for papers by Jean‐Marc Nabholtz
Rankless by CCL
2026